Allogene Therapeutics Inc (ALLO) stock saw a modest uptick, ending the day at $2.35 which represents a slight increase of $0.19 or 8.80% from the prior close of $2.16. The stock opened at $2.15 and ...
Rodman & Renshaw has recently initiated CorMedix Inc (CRMD) stock to Buy rating, as announced on August 26, 2024, according to Finviz. Earlier, on August 10, 2023, RBC Capital Mkts had initiated the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback